IEXLENS
Log inSign up
Trending searchesBTCETHSOLXRPDOGE

NVO

Novo Nordisk A/SNYSE
39.03 USDT-0.23%Binance perpetual · refreshed every 30s
24h value$390.6KOpen interest$828.8KFunding0.0000%novonordisk.com ↗
Post in room

Key filings

All filings on SEC ›

Earnings, material events (8-K), quarterly and annual reports, ownership reports

  • 2026-10-266-KCurrent report (foreign issuer)Source ↗
  • 2026-10-196-KCurrent report (foreign issuer)Source ↗
  • 2026-10-136-KCurrent report (foreign issuer)Source ↗
  • 2026-10-066-KCurrent report (foreign issuer)Source ↗
  • 2026-10-056-KCurrent report (foreign issuer)Source ↗
  • 2026-09-286-KCurrent report (foreign issuer)Source ↗
  • 2026-09-216-KCurrent report (foreign issuer)Source ↗
  • 2026-09-176-KCurrent report (foreign issuer)Source ↗
  • 2026-09-156-KCurrent report (foreign issuer)Source ↗
  • 2026-09-096-KCurrent report (foreign issuer)Source ↗
  • 2026-08-316-KCurrent report (foreign issuer)Source ↗
  • 2026-08-246-KCurrent report (foreign issuer)Source ↗
  • 2026-08-186-KCurrent report (foreign issuer)Source ↗
  • 2026-08-106-KCurrent report (foreign issuer)Source ↗
  • 2026-08-106-KCurrent report (foreign issuer)Source ↗

Filings are in English. Form and item labels are only a classification to help you navigate and do not interpret the filing.

Insider trades & planned sales

Stock transactions by officers and major holders (Form 4) and notices of proposed sale (Form 144)

✈ Contact on Telegram